SEC Form 4 · accession 0001493152-26-040513
Relay Therapeutics, Inc. · RLAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
SB INVESTMENT ADVISERS (UK) LTD
10% Owner
SOFTBANK VISION FUND (AIV M2) L.P.
10% Owner
SVF Pauling (Cayman) Ltd
10% Owner
Period of report
Aug 25, 2026
Accepted (ET)
Aug 28, 2026 · 9:01 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001812364
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 25, 2026 | S | 6,000,000 | $19.40 | D | 21,904,963 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Securities held of record by SVF Pauling (Cayman) Limited, a wholly owned subsidiary of SoftBank Vision Fund (AIV M2) L.P. ("AIV M2"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing AIV M2 in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of AIV M2, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF Pauling (Cayman) Limited's investments.